AZN CapEx to Revenue

AstraZeneca PLC Ordinary Shares · CapEx to Revenue

AZN logo

AZN CapEx to Revenue

Current (TTM)8.66%
AZN CapEx/Revenue (7.35% → 8.66%)
High-resolution chart · PNG

AZN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
10.0529%
8.662%
8.1102%
5.8097%
5.9288%
8.9033%
10.0411%
6.5332%
6.908%
11.0599%
11.653%
10.6311%
7.6971%
16.2929%
3.9942%
7.2621%
8.7478%
13.1738%
5.7212%
4.7548%
4.3138%
1.4769%
6.8014%
7.5071%
9.5996%
8.0633%
14.9255%
9.2377%
8.7986%
6.9551%
5.6962%
7.0313%
7.0495%
6.7354%
5.2431%
7.3491%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.